Kathryn Jones

12.6k total citations
59 papers, 1.9k citations indexed

About

Kathryn Jones is a scholar working on Molecular Biology, General Health Professions and Infectious Diseases. According to data from OpenAlex, Kathryn Jones has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in General Health Professions and 9 papers in Infectious Diseases. Recurrent topics in Kathryn Jones's work include Mental Health and Patient Involvement (9 papers), Vector-borne infectious diseases (8 papers) and Viral Infections and Vectors (7 papers). Kathryn Jones is often cited by papers focused on Mental Health and Patient Involvement (9 papers), Vector-borne infectious diseases (8 papers) and Viral Infections and Vectors (7 papers). Kathryn Jones collaborates with scholars based in United States, United Kingdom and Australia. Kathryn Jones's co-authors include Rob Baggott, Judith Allsop, Bradley V. Clineschmidt, David L. Williams, Edward V. Lis, Douglas J. Pettibone, Allen C. Steere, Eric J. Gowans, Floyd L. Culler and Lisa Glickstein and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Clinical Endocrinology & Metabolism and Biochemistry.

In The Last Decade

Kathryn Jones

58 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Jones United States 24 485 461 319 309 240 59 1.9k
Robert S. Chang United States 29 953 2.0× 252 0.5× 107 0.3× 398 1.3× 107 0.4× 129 3.4k
Peter Berger Austria 34 921 1.9× 251 0.5× 67 0.2× 207 0.7× 88 0.4× 118 4.0k
Sarah Dion France 26 1.4k 2.8× 274 0.6× 116 0.4× 110 0.4× 470 2.0× 71 3.7k
Lewis Thomas United States 35 554 1.1× 245 0.5× 141 0.4× 200 0.6× 104 0.4× 94 3.7k
Joseph Smith United States 26 956 2.0× 395 0.9× 46 0.1× 188 0.6× 91 0.4× 151 2.6k
Kathryn Berzins Sweden 29 938 1.9× 164 0.4× 312 1.0× 68 0.2× 397 1.7× 117 3.5k
Muntaser E. Ibrahim Sudan 33 1.2k 2.5× 259 0.6× 214 0.7× 195 0.6× 43 0.2× 99 4.2k
Tingting Yang China 28 796 1.6× 143 0.3× 78 0.2× 58 0.2× 420 1.8× 80 2.6k
George F. Lemp United States 23 391 0.8× 116 0.3× 85 0.3× 1.0k 3.3× 449 1.9× 36 2.4k
Michael McCarthy United States 21 468 1.0× 70 0.2× 120 0.4× 287 0.9× 68 0.3× 91 1.4k

Countries citing papers authored by Kathryn Jones

Since Specialization
Citations

This map shows the geographic impact of Kathryn Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Jones more than expected).

Fields of papers citing papers by Kathryn Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Jones. The network helps show where Kathryn Jones may publish in the future.

Co-authorship network of co-authors of Kathryn Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Jones. A scholar is included among the top collaborators of Kathryn Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Jones. Kathryn Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Qi, et al.. (2020). 5′-Nor-3-Deaza-1′,6′-Isoneplanocin, the Synthesis and Antiviral Study. Molecules. 25(17). 3865–3865. 2 indexed citations
3.
Baggott, Rob & Kathryn Jones. (2018). Representing Whom? U.K. Health Consumer and Patients’ Organizations in the Policy Process. Journal of Bioethical Inquiry. 15(3). 341–349. 8 indexed citations
4.
Baggott, Rob & Kathryn Jones. (2014). The Big Society in an age of austerity: threats and opportunities for Health Consumer and Patients' Organizations in England. Health Expectations. 18(6). 2164–2173. 11 indexed citations
5.
Allsop, Judith & Kathryn Jones. (2012). Quality Assurance in Medical Regulation: in an international context. Lincoln Repository (University of Lincoln). 5 indexed citations
6.
Gowans, Eric J., Stuart K. Roberts, Kathryn Jones, et al.. (2010). A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals. Journal of Hepatology. 53(4). 599–607. 49 indexed citations
8.
Jones, Kathryn, Robert Seward, Gil Ben‐Menachem, et al.. (2009). Strong IgG antibody responses to Borrelia burgdorferi glycolipids in patients with Lyme arthritis, a late manifestation of the infection. Clinical Immunology. 132(1). 93–102. 18 indexed citations
9.
Li, Shuo, Kathryn Jones, David J. Woollard, et al.. (2007). Defining target antigens for CD25+FOXP3+IFN‐γ regulatory T cells in chronic hepatitis C virus infection. Immunology and Cell Biology. 85(3). 197–204. 55 indexed citations
10.
Jones, Kathryn, et al.. (2004). DC preparations for therapy. Cytotherapy. 6(2). 99–104. 11 indexed citations
11.
Baggott, Rob, Judith Allsop, & Kathryn Jones. (2004). Representing the repressed? Health consumer groups and the national policy process. Policy & Politics. 32(3). 317–331. 9 indexed citations
12.
Allsop, Judith, Kathryn Jones, & Rob Baggott. (2004). Health consumer groups in the UK: a new social movement?. Sociology of Health & Illness. 26(6). 737–756. 121 indexed citations
13.
Gowans, Eric J., Kathryn Jones, Mandvi Bharadwaj, & David C. Jackson. (2004). Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. Journal of Clinical Virology. 30(4). 283–290. 29 indexed citations
15.
Williams, David L., et al.. (1993). Characterization of cloned human endothelin receptors. Life Sciences. 53(5). 407–414. 23 indexed citations
16.
Williams, David L., Kathryn Jones, Douglas J. Pettibone, Edward V. Lis, & Bradley V. Clineschmidt. (1991). Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes. Biochemical and Biophysical Research Communications. 175(2). 556–561. 339 indexed citations
17.
Jones, Kathryn, et al.. (1988). Inhibition by Prednisone of Growth Hormone (GH) Response to GH-Releasing Hormone in Normal Men. The Journal of Clinical Endocrinology & Metabolism. 67(6). 1258–1261. 67 indexed citations
18.
Culler, Floyd L., S. Kaufmann, Luciano G. Frigeri, & Kathryn Jones. (1988). Comparison of the Acute Metabolic Effects of 22,000-Dalton and 20,000-Dalton Growth Hormone in Human Subjects. Hormone and Metabolic Research. 20(2). 107–109. 6 indexed citations
19.
Dunn, Nathan, B. J. Preston, & Kathryn Jones. (1985). Unexplained acute backache in longstanding ankylosing spondylitis.. BMJ. 291(6509). 1632–1634. 12 indexed citations
20.
Say, Burhan, et al.. (1976). Familial translocation (3p 15p) with partial trisomy for the upper arm of chromosome 3 in two sibs. The Journal of Pediatrics. 88(3). 447–450. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026